Irina Cho

Irina Cho is an experienced finance professional currently serving as the Assistant Corporate Controller at Iovance Biotherapeutics, Inc. since May 2021. Previously, Irina held the position of Senior Manager in Financial Accounting Advisory Services at EY, where responsibilities included managing significant implementation projects for Revenue Recognition, the New Lease Standard, process improvement, IPO readiness, and financial statement preparation. With a foundational career at Ernst & Young, Irina progressed through various audit roles while specializing in audits of tech and biotech companies, internal control assessments, and international coordination of group audits. Irina holds a Master's degree in Accounting from the Finance University under the Government of the Russian Federation.